Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Omission of Whole-breast Radiotherapy Following Breast-conserving Surgery in Patients With Very Low Risk Ductal Carcinoma in Situ of the Breast

NCT03878342 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03878342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03878342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Omission of Whole-breast Radiotherapy Following Breast-conserving Surgery in Patients With Very Low Risk Ductal Carcinoma in Situ of the Breast
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 10, 2019
Completion date
November 14, 2034
Enrollment
295 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast conserving surgery, dcis, low risk dcis, radiotherapy omission